Impact of COVID-19 Outbreak on Respiratory Drug, Global Market Research Report 2020

June 2020 | 117 pages | ID: IDF82C6FB3CDEN
QYResearch

Abstracts

The global Respiratory Drug market is valued at US$ xx million in 2020 is expected to reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2021-2026.
This report focuses on Respiratory Drug volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Respiratory Drug market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan etc.
Market Segment Analysis
The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type, the Respiratory Drug market is segmented into

• Advair
• Symbicort turbuhaler
• Spiriva
• Xolair
• Ventolin
• Pulmicort
• Orkambi
• Relvar/breo ellipta
• Singulair
• Esbriet

Segment by Application

• Hospitals
• Home care

Global Respiratory Drug Market: Regional Analysis
The Respiratory Drug market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
The key regions covered in the Respiratory Drug market report are:
North America

• U.S.
• Canada

Europe

• Germany
• France
• U.K.
• Italy
• Russia

Asia-Pacific

• China
• Japan
• South Korea
• India
• Australia
• Taiwan
• Indonesia
• Thailand
• Malaysia
• Philippines
• Vietnam

Latin America

• Mexico
• Brazil
• Argentina

Middle East & Africa

• Turkey
• Saudi Arabia
• U.A.E

Global Respiratory Drug Market: Competitive Analysis
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
The major players in global Respiratory Drug market include:

• GSK
• Boehringer Ingelheim
• AstraZeneca
• Merck
• Novartis
• Omron
• Sunovion
• Air Liquide
• Aradigm
• Baxter
• Beximco Pharmaceuticals
• Compumedics
• Pfizer
• Draeger
• Roche
• Fisher & Paykel Healthcare
• GE Healthcare
• Genentech
• Grifols
• Hamilton Medical

Contents

1 RESPIRATORY DRUG MARKET OVERVIEW

1.1 Product Overview and Scope of Respiratory Drug
1.2 Respiratory Drug Segment by Type
  1.2.1 Global Respiratory Drug Sales Growth Rate Comparison by Type (2021-2026)
  1.2.2 Advair
  1.2.3 Symbicort turbuhaler
  1.2.4 Spiriva
  1.2.5 Xolair
  1.2.6 Ventolin
  1.2.7 Pulmicort
  1.2.8 Orkambi
  1.2.9 Relvar/breo ellipta
  1.2.10 Singulair
  1.2.11 Esbriet
1.3 Respiratory Drug Segment by Application
  1.3.1 Respiratory Drug Sales Comparison by Application: 2020 VS 2026
  1.3.2 Hospitals
  1.3.3 Home care
1.4 Global Respiratory Drug Market Size Estimates and Forecasts
  1.4.1 Global Respiratory Drug Revenue 2015-2026
  1.4.2 Global Respiratory Drug Sales 2015-2026
  1.4.3 Respiratory Drug Market Size by Region: 2020 Versus 2026

2 GLOBAL RESPIRATORY DRUG MARKET COMPETITION BY MANUFACTURERS

2.1 Global Respiratory Drug Sales Market Share by Manufacturers (2015-2020)
2.2 Global Respiratory Drug Revenue Share by Manufacturers (2015-2020)
2.3 Global Respiratory Drug Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Respiratory Drug Manufacturing Sites, Area Served, Product Type
2.5 Respiratory Drug Market Competitive Situation and Trends
  2.5.1 Respiratory Drug Market Concentration Rate
  2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
  2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Respiratory Drug Players (Opinion Leaders)

3 RESPIRATORY DRUG RETROSPECTIVE MARKET SCENARIO BY REGION

3.1 Global Respiratory Drug Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Respiratory Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Respiratory Drug Market Facts & Figures by Country
  3.3.1 North America Respiratory Drug Sales by Country
  3.3.2 North America Respiratory Drug Sales by Country
  3.3.3 U.S.
  3.3.4 Canada
3.4 Europe Respiratory Drug Market Facts & Figures by Country
  3.4.1 Europe Respiratory Drug Sales by Country
  3.4.2 Europe Respiratory Drug Sales by Country
  3.4.3 Germany
  3.4.4 France
  3.4.5 U.K.
  3.4.6 Italy
  3.4.7 Russia
3.5 Asia Pacific Respiratory Drug Market Facts & Figures by Region
  3.5.1 Asia Pacific Respiratory Drug Sales by Region
  3.5.2 Asia Pacific Respiratory Drug Sales by Region
  3.5.3 China
  3.5.4 Japan
  3.5.5 South Korea
  3.5.6 India
  3.5.7 Australia
  3.5.8 Taiwan
  3.5.9 Indonesia
  3.5.10 Thailand
  3.5.11 Malaysia
  3.5.12 Philippines
  3.5.13 Vietnam
3.6 Latin America Respiratory Drug Market Facts & Figures by Country
  3.6.1 Latin America Respiratory Drug Sales by Country
  3.6.2 Latin America Respiratory Drug Sales by Country
  3.6.3 Mexico
  3.6.3 Brazil
  3.6.3 Argentina
3.7 Middle East and Africa Respiratory Drug Market Facts & Figures by Country
  3.7.1 Middle East and Africa Respiratory Drug Sales by Country
  3.7.2 Middle East and Africa Respiratory Drug Sales by Country
  3.7.3 Turkey
  3.7.4 Saudi Arabia
  3.7.5 U.A.E

4 GLOBAL RESPIRATORY DRUG HISTORIC MARKET ANALYSIS BY TYPE

4.1 Global Respiratory Drug Sales Market Share by Type (2015-2020)
4.2 Global Respiratory Drug Revenue Market Share by Type (2015-2020)
4.3 Global Respiratory Drug Price Market Share by Type (2015-2020)
4.4 Global Respiratory Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 GLOBAL RESPIRATORY DRUG HISTORIC MARKET ANALYSIS BY APPLICATION

5.1 Global Respiratory Drug Sales Market Share by Application (2015-2020)
5.2 Global Respiratory Drug Revenue Market Share by Application (2015-2020)
5.3 Global Respiratory Drug Price by Application (2015-2020)

6 COMPANY PROFILES AND KEY FIGURES IN RESPIRATORY DRUG BUSINESS

6.1 GSK
  6.1.1 Corporation Information
  6.1.2 GSK Description, Business Overview and Total Revenue
  6.1.3 GSK Respiratory Drug Sales, Revenue and Gross Margin (2015-2020)
  6.1.4 GSK Products Offered
  6.1.5 GSK Recent Development
6.2 Boehringer Ingelheim
  6.2.1 Boehringer Ingelheim Respiratory Drug Production Sites and Area Served
  6.2.2 Boehringer Ingelheim Description, Business Overview and Total Revenue
  6.2.3 Boehringer Ingelheim Respiratory Drug Sales, Revenue and Gross Margin (2015-2020)
  6.2.4 Boehringer Ingelheim Products Offered
  6.2.5 Boehringer Ingelheim Recent Development
6.3 AstraZeneca
  6.3.1 AstraZeneca Respiratory Drug Production Sites and Area Served
  6.3.2 AstraZeneca Description, Business Overview and Total Revenue
  6.3.3 AstraZeneca Respiratory Drug Sales, Revenue and Gross Margin (2015-2020)
  6.3.4 AstraZeneca Products Offered
  6.3.5 AstraZeneca Recent Development
6.4 Merck
  6.4.1 Merck Respiratory Drug Production Sites and Area Served
  6.4.2 Merck Description, Business Overview and Total Revenue
  6.4.3 Merck Respiratory Drug Sales, Revenue and Gross Margin (2015-2020)
  6.4.4 Merck Products Offered
  6.4.5 Merck Recent Development
6.5 Novartis
  6.5.1 Novartis Respiratory Drug Production Sites and Area Served
  6.5.2 Novartis Description, Business Overview and Total Revenue
  6.5.3 Novartis Respiratory Drug Sales, Revenue and Gross Margin (2015-2020)
  6.5.4 Novartis Products Offered
  6.5.5 Novartis Recent Development
6.6 Omron
  6.6.1 Omron Respiratory Drug Production Sites and Area Served
  6.6.2 Omron Description, Business Overview and Total Revenue
  6.6.3 Omron Respiratory Drug Sales, Revenue and Gross Margin (2015-2020)
  6.6.4 Omron Products Offered
  6.6.5 Omron Recent Development
6.7 Sunovion
  6.6.1 Sunovion Respiratory Drug Production Sites and Area Served
  6.6.2 Sunovion Description, Business Overview and Total Revenue
  6.6.3 Sunovion Respiratory Drug Sales, Revenue and Gross Margin (2015-2020)
  6.4.4 Sunovion Products Offered
  6.7.5 Sunovion Recent Development
6.8 Air Liquide
  6.8.1 Air Liquide Respiratory Drug Production Sites and Area Served
  6.8.2 Air Liquide Description, Business Overview and Total Revenue
  6.8.3 Air Liquide Respiratory Drug Sales, Revenue and Gross Margin (2015-2020)
  6.8.4 Air Liquide Products Offered
  6.8.5 Air Liquide Recent Development
6.9 Aradigm
  6.9.1 Aradigm Respiratory Drug Production Sites and Area Served
  6.9.2 Aradigm Description, Business Overview and Total Revenue
  6.9.3 Aradigm Respiratory Drug Sales, Revenue and Gross Margin (2015-2020)
  6.9.4 Aradigm Products Offered
  6.9.5 Aradigm Recent Development
6.10 Baxter
  6.10.1 Baxter Respiratory Drug Production Sites and Area Served
  6.10.2 Baxter Description, Business Overview and Total Revenue
  6.10.3 Baxter Respiratory Drug Sales, Revenue and Gross Margin (2015-2020)
  6.10.4 Baxter Products Offered
  6.10.5 Baxter Recent Development
6.11 Beximco Pharmaceuticals
  6.11.1 Beximco Pharmaceuticals Respiratory Drug Production Sites and Area Served
  6.11.2 Beximco Pharmaceuticals Respiratory Drug Description, Business Overview and Total Revenue
  6.11.3 Beximco Pharmaceuticals Respiratory Drug Sales, Revenue and Gross Margin (2015-2020)
  6.11.4 Beximco Pharmaceuticals Products Offered
  6.11.5 Beximco Pharmaceuticals Recent Development
6.12 Compumedics
  6.12.1 Compumedics Respiratory Drug Production Sites and Area Served
  6.12.2 Compumedics Respiratory Drug Description, Business Overview and Total Revenue
  6.12.3 Compumedics Respiratory Drug Sales, Revenue and Gross Margin (2015-2020)
  6.12.4 Compumedics Products Offered
  6.12.5 Compumedics Recent Development
6.13 Pfizer
  6.13.1 Pfizer Respiratory Drug Production Sites and Area Served
  6.13.2 Pfizer Respiratory Drug Description, Business Overview and Total Revenue
  6.13.3 Pfizer Respiratory Drug Sales, Revenue and Gross Margin (2015-2020)
  6.13.4 Pfizer Products Offered
  6.13.5 Pfizer Recent Development
6.14 Draeger
  6.14.1 Draeger Respiratory Drug Production Sites and Area Served
  6.14.2 Draeger Respiratory Drug Description, Business Overview and Total Revenue
  6.14.3 Draeger Respiratory Drug Sales, Revenue and Gross Margin (2015-2020)
  6.14.4 Draeger Products Offered
  6.14.5 Draeger Recent Development
6.15 Roche
  6.15.1 Roche Respiratory Drug Production Sites and Area Served
  6.15.2 Roche Respiratory Drug Description, Business Overview and Total Revenue
  6.15.3 Roche Respiratory Drug Sales, Revenue and Gross Margin (2015-2020)
  6.15.4 Roche Products Offered
  6.15.5 Roche Recent Development
6.16 Fisher & Paykel Healthcare
  6.16.1 Fisher & Paykel Healthcare Respiratory Drug Production Sites and Area Served
  6.16.2 Fisher & Paykel Healthcare Respiratory Drug Description, Business Overview and Total Revenue
  6.16.3 Fisher & Paykel Healthcare Respiratory Drug Sales, Revenue and Gross Margin (2015-2020)
  6.16.4 Fisher & Paykel Healthcare Products Offered
  6.16.5 Fisher & Paykel Healthcare Recent Development
6.17 GE Healthcare
  6.17.1 GE Healthcare Respiratory Drug Production Sites and Area Served
  6.17.2 GE Healthcare Respiratory Drug Description, Business Overview and Total Revenue
  6.17.3 GE Healthcare Respiratory Drug Sales, Revenue and Gross Margin (2015-2020)
  6.17.4 GE Healthcare Products Offered
  6.17.5 GE Healthcare Recent Development
6.18 Genentech
  6.18.1 Genentech Respiratory Drug Production Sites and Area Served
  6.18.2 Genentech Respiratory Drug Description, Business Overview and Total Revenue
  6.18.3 Genentech Respiratory Drug Sales, Revenue and Gross Margin (2015-2020)
  6.18.4 Genentech Products Offered
  6.18.5 Genentech Recent Development
6.19 Grifols
  6.19.1 Grifols Respiratory Drug Production Sites and Area Served
  6.19.2 Grifols Respiratory Drug Description, Business Overview and Total Revenue
  6.19.3 Grifols Respiratory Drug Sales, Revenue and Gross Margin (2015-2020)
  6.19.4 Grifols Products Offered
  6.19.5 Grifols Recent Development
6.20 Hamilton Medical
  6.20.1 Hamilton Medical Respiratory Drug Production Sites and Area Served
  6.20.2 Hamilton Medical Respiratory Drug Description, Business Overview and Total Revenue
  6.20.3 Hamilton Medical Respiratory Drug Sales, Revenue and Gross Margin (2015-2020)
  6.20.4 Hamilton Medical Products Offered
  6.20.5 Hamilton Medical Recent Development

7 RESPIRATORY DRUG MANUFACTURING COST ANALYSIS

7.1 Respiratory Drug Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Key Raw Materials Price Trend
  7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Respiratory Drug
7.4 Respiratory Drug Industrial Chain Analysis

8 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS

8.1 Marketing Channel
8.2 Respiratory Drug Distributors List
8.3 Respiratory Drug Customers

9 MARKET DYNAMICS

9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis

10 GLOBAL MARKET FORECAST

10.1 Global Respiratory Drug Market Estimates and Projections by Type
  10.1.1 Global Forecasted Sales of Respiratory Drug by Type (2021-2026)
  10.1.2 Global Forecasted Revenue of Respiratory Drug by Type (2021-2026)
10.2 Respiratory Drug Market Estimates and Projections by Application
  10.2.1 Global Forecasted Sales of Respiratory Drug by Application (2021-2026)
  10.2.2 Global Forecasted Revenue of Respiratory Drug by Application (2021-2026)
10.3 Respiratory Drug Market Estimates and Projections by Region
  10.3.1 Global Forecasted Sales of Respiratory Drug by Region (2021-2026)
  10.3.2 Global Forecasted Revenue of Respiratory Drug by Region (2021-2026)
10.4 North America Respiratory Drug Estimates and Projections (2021-2026)
10.5 Europe Respiratory Drug Estimates and Projections (2021-2026)
10.6 Asia Pacific Respiratory Drug Estimates and Projections (2021-2026)
10.7 Latin America Respiratory Drug Estimates and Projections (2021-2026)
10.8 Middle East and Africa Respiratory Drug Estimates and Projections (2021-2026)

11 RESEARCH FINDING AND CONCLUSION

12 METHODOLOGY AND DATA SOURCE

12.1 Methodology/Research Approach
  12.1.1 Research Programs/Design
  12.1.2 Market Size Estimation
  12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
  12.2.1 Secondary Sources
  12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Global Respiratory Drug Sales (K Pcs) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Respiratory Drug Sales (K Pcs) Comparison by Application: 2020 VS 2026
Table 3. Global Respiratory Drug Market Size by Type (K Pcs) (US$ Million) (2020 VS 2026)
Table 4. Global Key Respiratory Drug Manufacturers Covered in This Study
Table 5. Global Respiratory Drug Sales (K Pcs) by Manufacturers (2015-2020)
Table 6. Global Respiratory Drug Sales Share by Manufacturers (2015-2020)
Table 7. Global Respiratory Drug Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Respiratory Drug Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Respiratory Drug Average Price (USD/Pcs) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Respiratory Drug Sales Sites and Area Served
Table 11. Manufacturers Respiratory Drug Product Types
Table 12. Global Respiratory Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Respiratory Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Respiratory Drug as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Respiratory Drug Players
Table 16. Global Respiratory Drug Sales (K Pcs) by Region (2015-2020)
Table 17. Global Respiratory Drug Sales Market Share by Region (2015-2020)
Table 18. Global Respiratory Drug Revenue (Million US$) by Region (2015-2020)
Table 19. Global Respiratory Drug Revenue Market Share by Region (2015-2020)
Table 20. North America Respiratory Drug Sales by Country (2015-2020) (K Pcs)
Table 21. North America Respiratory Drug Sales Market Share by Country (2015-2020)
Table 22. North America Respiratory Drug Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Respiratory Drug Revenue Market Share by Country (2015-2020)
Table 24. Europe Respiratory Drug Sales by Country (2015-2020) (K Pcs)
Table 25. Europe Respiratory Drug Sales Market Share by Country (2015-2020)
Table 26. Europe Respiratory Drug Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Respiratory Drug Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Respiratory Drug Sales by Region (2015-2020) (K Pcs)
Table 29. Asia Pacific Respiratory Drug Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Respiratory Drug Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Respiratory Drug Revenue Market Share by Region (2015-2020)
Table 32. Latin America Respiratory Drug Sales by Country (2015-2020) (K Pcs)
Table 33. Latin America Respiratory Drug Sales Market Share by Country (2015-2020)
Table 34. Latin America Respiratory Drug Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Respiratory Drug Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Respiratory Drug Sales by Country (2015-2020) (K Pcs)
Table 37. Middle East and Africa Respiratory Drug Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Respiratory Drug Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Respiratory Drug Revenue Market Share by Country (2015-2020)
Table 40. Global Respiratory Drug Sales (K Pcs) by Type (2015-2020)
Table 41. Global Respiratory Drug Sales Share by Type (2015-2020)
Table 42. Global Respiratory Drug Revenue (Million US$) by Type (2015-2020)
Table 43. Global Respiratory Drug Revenue Share by Type (2015-2020)
Table 44. Global Respiratory Drug Price (USD/Pcs) by Type (2015-2020)
Table 45. Global Respiratory Drug Sales (K Pcs) by Application (2015-2020)
Table 46. Global Respiratory Drug Sales Market Share by Application (2015-2020)
Table 47. Global Respiratory Drug Sales Growth Rate by Application (2015-2020)
Table 48. GSK Respiratory Drug Corporation Information
Table 49. GSK Description and Business Overview
Table 50. GSK Respiratory Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 51. GSK Main Product
Table 52. GSK Recent Development
Table 53. Boehringer Ingelheim Respiratory Drug Corporation Information
Table 54. Boehringer Ingelheim Corporation Information
Table 55. Boehringer Ingelheim Respiratory Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 56. Boehringer Ingelheim Main Product
Table 57. Boehringer Ingelheim Recent Development
Table 58. AstraZeneca Respiratory Drug Corporation Information
Table 59. AstraZeneca Corporation Information
Table 60. AstraZeneca Respiratory Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 61. AstraZeneca Main Product
Table 62. AstraZeneca Recent Development
Table 63. Merck Respiratory Drug Corporation Information
Table 64. Merck Corporation Information
Table 65. Merck Respiratory Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 66. Merck Main Product
Table 67. Merck Recent Development
Table 68. Novartis Respiratory Drug Corporation Information
Table 69. Novartis Corporation Information
Table 70. Novartis Respiratory Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 71. Novartis Main Product
Table 72. Novartis Recent Development
Table 73. Omron Respiratory Drug Corporation Information
Table 74. Omron Corporation Information
Table 75. Omron Respiratory Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 76. Omron Main Product
Table 77. Omron Recent Development
Table 78. Sunovion Respiratory Drug Corporation Information
Table 79. Sunovion Corporation Information
Table 80. Sunovion Respiratory Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 81. Sunovion Main Product
Table 82. Sunovion Recent Development
Table 83. Air Liquide Respiratory Drug Corporation Information
Table 84. Air Liquide Corporation Information
Table 85. Air Liquide Respiratory Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 86. Air Liquide Main Product
Table 87. Air Liquide Recent Development
Table 88. Aradigm Respiratory Drug Corporation Information
Table 89. Aradigm Corporation Information
Table 90. Aradigm Respiratory Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 91. Aradigm Main Product
Table 92. Aradigm Recent Development
Table 93. Baxter Respiratory Drug Corporation Information
Table 94. Baxter Corporation Information
Table 95. Baxter Respiratory Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 96. Baxter Main Product
Table 97. Baxter Recent Development
Table 98. Beximco Pharmaceuticals Respiratory Drug Corporation Information
Table 99. Beximco Pharmaceuticals Corporation Information
Table 100. Beximco Pharmaceuticals Respiratory Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 101. Beximco Pharmaceuticals Main Product
Table 102. Beximco Pharmaceuticals Recent Development
Table 103. Compumedics Respiratory Drug Corporation Information
Table 104. Compumedics Corporation Information
Table 105. Compumedics Respiratory Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 106. Compumedics Main Product
Table 107. Compumedics Recent Development
Table 108. Pfizer Respiratory Drug Corporation Information
Table 109. Pfizer Corporation Information
Table 110. Pfizer Respiratory Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 111. Pfizer Main Product
Table 112. Pfizer Recent Development
Table 113. Draeger Respiratory Drug Corporation Information
Table 114. Draeger Corporation Information
Table 115. Draeger Respiratory Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 116. Draeger Main Product
Table 117. Draeger Recent Development
Table 118. Roche Respiratory Drug Corporation Information
Table 119. Roche Corporation Information
Table 120. Roche Respiratory Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 121. Roche Main Product
Table 122. Roche Recent Development
Table 123. Fisher & Paykel Healthcare Respiratory Drug Corporation Information
Table 124. Fisher & Paykel Healthcare Corporation Information
Table 125. Fisher & Paykel Healthcare Respiratory Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 126. Fisher & Paykel Healthcare Main Product
Table 127. Fisher & Paykel Healthcare Recent Development
Table 128. GE Healthcare Respiratory Drug Corporation Information
Table 129. GE Healthcare Corporation Information
Table 130. GE Healthcare Respiratory Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 131. GE Healthcare Main Product
Table 132. GE Healthcare Recent Development
Table 133. Genentech Respiratory Drug Corporation Information
Table 134. Genentech Corporation Information
Table 135. Genentech Respiratory Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 136. Genentech Main Product
Table 137. Genentech Recent Development
Table 138. Grifols Respiratory Drug Corporation Information
Table 139. Grifols Corporation Information
Table 140. Grifols Respiratory Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 141. Grifols Main Product
Table 142. Grifols Recent Development
Table 143. Hamilton Medical Respiratory Drug Corporation Information
Table 144. Hamilton Medical Corporation Information
Table 145. Hamilton Medical Respiratory Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 146. Hamilton Medical Main Product
Table 147. Hamilton Medical Recent Development
Table 148. Sales Base and Market Concentration Rate of Raw Material
Table 149. Key Suppliers of Raw Materials
Table 150. Respiratory Drug Distributors List
Table 151. Respiratory Drug Customers List
Table 152. Market Key Trends
Table 153. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 154. Key Challenges
Table 155. Global Respiratory Drug Sales (K Pcs) Forecast by Type (2021-2026)
Table 156. Global Respiratory Drug Sales Market Share Forecast by Type (2021-2026)
Table 157. Global Respiratory Drug Revenue (Million US$) Forecast by Type (2021-2026)
Table 158. Global Respiratory Drug Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 159. Global Respiratory Drug Sales (K Pcs) Forecast by Application (2021-2026)
Table 160. Global Respiratory Drug Revenue (Million US$) Forecast by Application (2021-2026)
Table 161. Global Respiratory Drug Sales (K Pcs) Forecast by Region (2021-2026)
Table 162. Global Respiratory Drug Sales Market Share Forecast by Region (2021-2026)
Table 163. Global Respiratory Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 164. Global Respiratory Drug Revenue Market Share Forecast by Region (2021-2026)
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Respiratory Drug
Figure 2. Global Respiratory Drug Sales Market Share by Type: 2020 VS 2026
Figure 3. Advair Product Picture
Figure 4. Symbicort turbuhaler Product Picture
Figure 5. Spiriva Product Picture
Figure 6. Xolair Product Picture
Figure 7. Ventolin Product Picture
Figure 8. Pulmicort Product Picture
Figure 9. Orkambi Product Picture
Figure 10. Relvar/breo ellipta Product Picture
Figure 11. Singulair Product Picture
Figure 12. Esbriet Product Picture
Figure 13. Global Respiratory Drug Consumption Market Share by Application: 2020 VS 2026
Figure 14. Hospitals
Figure 15. Home care
Figure 16. Global Respiratory Drug Market Size 2015-2026 (US$ Million)
Figure 17. Global Respiratory Drug Sales Capacity (K Pcs) (2015-2026)
Figure 18. Global Respiratory Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 19. Respiratory Drug Sales Share by Manufacturers in 2020
Figure 20. Global Respiratory Drug Revenue Share by Manufacturers in 2019
Figure 21. The Global 5 and 10 Largest Players: Market Share by Respiratory Drug Revenue in 2019
Figure 22. Respiratory Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Respiratory Drug Sales Market Share by Region (2015-2020)
Figure 24. Global Respiratory Drug Sales Market Share by Region in 2019
Figure 25. Global Respiratory Drug Revenue Market Share by Region (2015-2020)
Figure 26. Global Respiratory Drug Revenue Market Share by Region in 2019
Figure 27. North America Respiratory Drug Sales Market Share by Country in 2019
Figure 28. North America Respiratory Drug Revenue Market Share by Country in 2019
Figure 29. U.S. Respiratory Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 30. U.S. Respiratory Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 31. Canada Respiratory Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 32. Canada Respiratory Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 33. Europe Respiratory Drug Sales Market Share by Country in 2019
Figure 34. Europe Respiratory Drug Revenue Market Share by Country in 2019
Figure 35. Germany Respiratory Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 36. Germany Respiratory Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. France Respiratory Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 38. France Respiratory Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. U.K. Respiratory Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 40. U.K. Respiratory Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. Italy Respiratory Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 42. Italy Respiratory Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. Russia Respiratory Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 44. Russia Respiratory Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. Asia Pacific Respiratory Drug Sales Market Share by Region in 2019
Figure 46. Asia Pacific Respiratory Drug Revenue Market Share by Region in 2019
Figure 47. China Respiratory Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. China Respiratory Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Japan Respiratory Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. Japan Respiratory Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. South Korea Respiratory Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. South Korea Respiratory Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. India Respiratory Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. India Respiratory Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Australia Respiratory Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 56. Australia Respiratory Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Taiwan Respiratory Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 58. Taiwan Respiratory Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Indonesia Respiratory Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 60. Indonesia Respiratory Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Thailand Respiratory Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 62. Thailand Respiratory Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Malaysia Respiratory Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 64. Malaysia Respiratory Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Philippines Respiratory Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. Philippines Respiratory Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Vietnam Respiratory Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. Vietnam Respiratory Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Latin America Respiratory Drug Sales Market Share by Country in 2019
Figure 70. Latin America Respiratory Drug Revenue Market Share by Country in 2019
Figure 71. Mexico Respiratory Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. Mexico Respiratory Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Brazil Respiratory Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Brazil Respiratory Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Argentina Respiratory Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Argentina Respiratory Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Middle East and Africa Respiratory Drug Sales Market Share by Country in 2019
Figure 78. Middle East and Africa Respiratory Drug Revenue Market Share by Country in 2019
Figure 79. Turkey Respiratory Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Turkey Respiratory Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Saudi Arabia Respiratory Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Saudi Arabia Respiratory Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. U.A.E Respiratory Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 84. U.A.E Respiratory Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Sales Market Share of Respiratory Drug by Type (2015-2020)
Figure 86. Sales Market Share of Respiratory Drug by Type in 2019
Figure 87. Revenue Share of Respiratory Drug by Type (2015-2020)
Figure 88. Revenue Market Share of Respiratory Drug by Type in 2019
Figure 89. Global Respiratory Drug Sales Growth by Type (2015-2020) (K Pcs)
Figure 90. Global Respiratory Drug Sales Market Share by Application (2015-2020)
Figure 91. Global Respiratory Drug Sales Market Share by Application in 2019
Figure 92. Global Revenue Share of Respiratory Drug by Application (2015-2020)
Figure 93. Global Revenue Share of Respiratory Drug by Application in 2020
Figure 94. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 99. Omron Total Revenue (US$ Million): 2019 Compared with 2018
Figure 100. Sunovion Total Revenue (US$ Million): 2019 Compared with 2018
Figure 101. Air Liquide Total Revenue (US$ Million): 2019 Compared with 2018
Figure 102. Aradigm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 103. Baxter Total Revenue (US$ Million): 2019 Compared with 2018
Figure 104. Beximco Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 105. Compumedics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 106. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 107. Draeger Total Revenue (US$ Million): 2019 Compared with 2018
Figure 108. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Fisher & Paykel Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. GE Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Genentech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Grifols Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Hamilton Medical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Price Trend of Key Raw Materials
Figure 115. Manufacturing Cost Structure of Respiratory Drug
Figure 116. Manufacturing Process Analysis of Respiratory Drug
Figure 117. Respiratory Drug Industrial Chain Analysis
Figure 118. Channels of Distribution
Figure 119. Distributors Profiles
Figure 120. Porter's Five Forces Analysis
Figure 121. North America Respiratory Drug Sales (K Pcs) and Growth Rate Forecast (2021-2026)
Figure 122. North America Respiratory Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 123. Europe Respiratory Drug Sales (K Pcs) and Growth Rate Forecast (2021-2026)
Figure 124. Europe Respiratory Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 125. Latin America Respiratory Drug Sales (K Pcs) and Growth Rate Forecast (2021-2026)
Figure 126. Latin America Respiratory Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 127. Middle East and Africa Respiratory Drug Sales (K Pcs) and Growth Rate Forecast (2021-2026)
Figure 128. Middle East and Africa Respiratory Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 129. Asia Pacific Respiratory Drug Sales (K Pcs) and Growth Rate Forecast (2021-2026)
Figure 130. Asia Pacific Respiratory Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 131. Bottom-up and Top-down Approaches for This Report
Figure 132. Data Triangulation
Figure 133. Key Executives Interviewed